231 related articles for article (PubMed ID: 2868029)
1. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Klimt CR; Knatterud GL; Stamler J; Meier P
J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
[TBL] [Abstract][Full Text] [Related]
2. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
Circulation; 1980 Sep; 62(3):449-61. PubMed ID: 7398002
[TBL] [Abstract][Full Text] [Related]
3. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
4. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
[TBL] [Abstract][Full Text] [Related]
5. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
6. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
7. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
8. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.
Lewis HD; Davis JW; Archibald DG; Steinke WE; Smitherman TC; Doherty JE; Schnaper HW; LeWinter MM; Linares E; Pouget JM; Sabharwal SC; Chesler E; DeMots H
N Engl J Med; 1983 Aug; 309(7):396-403. PubMed ID: 6135989
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
[TBL] [Abstract][Full Text] [Related]
11. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
White HD; French JK; Hamer AW; Brown MA; Williams BF; Ormiston JA; Cross DB
J Am Coll Cardiol; 1995 Jan; 25(1):218-23. PubMed ID: 7798505
[TBL] [Abstract][Full Text] [Related]
12. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group.
Stroke; 1985; 16(3):406-15. PubMed ID: 2860740
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.
JAMA; 1980 Feb; 243(7):661-9. PubMed ID: 6985998
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
17. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute complications after percutaneous transluminal coronary angioplasty.
Bourassa MG; Schwartz L; Lespérance J; Eastwood C; Kazim F
Thromb Res Suppl; 1990; 12():51-8. PubMed ID: 2082488
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
20. Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group.
Ishikawa K; Kanamasa K; Hama J; Ogawa I; Takenaka T; Naito T; Yamamoto T; Nakai S; Oyaizu M; Kimura A; Yamamoto K; Katori R
Jpn Circ J; 1997 Jan; 61(1):38-45. PubMed ID: 9070958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
